Skip to main content

Advertisement

SpringerLink
Log in

Topical Imiquimod to Treat Recurrent Breast Cancer

  • Letter to the Editor
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. HJ Burstein K Polyak JS Wong SC Lester CM Kaelin (2004) ArticleTitleDuctal carcinoma in situ of the breast. N Engl J Med 350 1430–1441 Occurrence Handle10.1056/NEJMra031301 Occurrence Handle15070793

    Article  PubMed  Google Scholar 

  2. KW Barber MB Dockerty OT Clagett (1961) ArticleTitleInflammatory carcinoma of the breast. Surg Gynec Obstet 112 406–410 Occurrence Handle13686772

    PubMed  Google Scholar 

  3. UR Hengge B Benninghoff T Ruzicka M Goos (2001) ArticleTitleTopical immunomodulators – progress towards treating inflammation, infection and cancer? Lancet Infect Dis 1 189–198 Occurrence Handle10.1016/S1473-3099(01)00095-0 Occurrence Handle11871495

    Article  PubMed  Google Scholar 

  4. S Nair C McLaughlin A Weizer Z Su D Boczkowski J Dannull J Vieweg E Gilboa (2003) ArticleTitleInjection of immature dendritic cells into adjuvant-treated skin obviates the need for ex vivo maturation. J Immunol 171 6275–6282 Occurrence Handle14634145

    PubMed  Google Scholar 

  5. M Shackleton ID Davis W Hopkins et al. (2004) ArticleTitleThe impact of imiquimod, a toll-like receptor-7 ligand (TLR7L), on the immunogenicity of melanoma peptide vaccination with adjuvant Flt3 ligand. Cancer Immunity 4 9 Occurrence Handle15384929

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Dermatology, Heinrich-Heine-University of Düsseldorf, Düsseldorf, Germany

    Ulrich R. Hengge

  2. Department of Radiation Therapy, Heinrich-Heine University, Düsseldorf, Germany

    Stephan Roth

  3. Institute of Pathology, University of Leipzig, Leipzig, Germany

    Andrea Tannapfel

Authors
  1. Ulrich R. Hengge
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Stephan Roth
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Andrea Tannapfel
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ulrich R. Hengge.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hengge, U.R., Roth, S. & Tannapfel, A. Topical Imiquimod to Treat Recurrent Breast Cancer. Breast Cancer Res Treat 94, 93–94 (2005). https://doi.org/10.1007/s10549-005-7017-2

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10549-005-7017-2

Keywords

Search

Navigation